Immune Group

مادة اعلانية

Latest Update: 18 Nov 2024 13:55 Abu Dhabi Time.

Market Status: Closed

MCGS

Immune Group

4.61

QAR

-0.001

-0.02%

Open

4.61

Prev Close

4.61

PX_VOLUME

390,370

MARKET CAP (M)

1,287.31

DAY RANGE

4.60 - 4.67

52 WEEKS

3.90 - 5.64

Stock Statistics

Yearly Change

-18.05%

Listed Shares (Million)

281.44

Earnings Multiple

25.29

Average 30-day trading volume

1,257,054.47

Price-to-book ratio

1.32

Earnings Per Share

0.23

Previous Dividend Distribution

0.22

Dividend Yield

4.77%

Financial Summary

Quarterly
Annual

Income Statements

	Period Ending:	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023
Total Revenue		123.54	128.79	130.10	130.01	109.24	118.67	128.09
Gross Profit		44.92	44.91	40.41	36.34	35.52	41.11	40.47
Operating Income		23.54	23.84	20.10	15.62	17.02	22.54	18.95
Profit Margin		20.03	19.89	15.20	11.78	15.61	19.45	14.68

	Period Ending:	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Total Revenue		486.31	487.17	483.63	476.80
Gross Profit		147.59	160.95	160.43	161.84
Operating Income		60.87	75.04	77.23	83.09
Profit Margin		13.51	16.25	16.35	17.93

Balance Sheet

	Period Ending:	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023
Total Assets		1,395.20	1,371.24	1,364.86	1,346.17	1,348.12	1,346.46	1,410.13
Total Liabilities		407.92	414.63	336.30	333.71	334.32	346.49	428.55
Total Equity		987.28	956.61	1,028.56	1,012.46	1,013.80	999.97	981.58

Cash Flows Statements - Coming Soon

* In Million of Qatar Riyal

Reminder: The financial information on this website is delayed information that are originates from certified data providers in the financial markets, who retain the rights and intellectual property of this data, absolving ADMN of any responsibility.